(Q1)May 31, 2021 | (FY)Feb 28, 2021 | (Q4)Feb 28, 2021 | (Q3)Nov 30, 2020 | (Q2)Aug 31, 2020 | (Q1)May 31, 2020 | (FY)Feb 29, 2020 | (Q4)Feb 29, 2020 | (Q3)Nov 30, 2019 | (Q2)Aug 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 267.91%28.1K | 30.75%-61.26K | -112.76%-22.19K | 72.31%-9.53K | -19.28%-12.8K | 49.09%-16.74K | -88.46K | -10.43K | -34.43K | -10.73K |
Net income from continuing operations | -87.25%-15.12K | 10.72%-109.52K | -644.67%-84.75K | 7.37%-5.87K | 87.09%-10.82K | 61.74%-8.08K | ---122.67K | ---11.38K | ---6.34K | ---83.84K |
Asset impairment expenditure | ---- | --27.04K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | --47.69K | --0 | --0 | ---- |
Other non cashItems | -222.78%-581 | -381.58%-3.16K | 52.01%-299 | ---1.29K | ---1.4K | ---180 | ---657 | ---623 | ---- | ---- |
Change In working capital | 616.65%43.81K | 290.21%24.38K | 2,172.91%35.82K | 91.54%-2.37K | -102.31%-586 | 27.89%-8.48K | ---12.82K | --1.58K | ---28.05K | --25.42K |
-Change in prepaid assets | 148.22%1.37K | -512.05%-3.91K | -1,256.78%-4.1K | 261.11%1.37K | -87.89%1.65K | 81.13%-2.83K | ---639 | --354 | --378 | --13.63K |
-Change in payables and accrued expense | 851.45%42.44K | 332.30%28.29K | 3,166.45%39.92K | 86.85%-3.74K | -118.97%-2.24K | -274.27%-5.65K | ---12.18K | --1.22K | ---28.43K | --11.79K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 267.91%28.1K | 30.75%-61.26K | -112.76%-22.19K | 72.31%-9.53K | -19.28%-12.8K | 49.09%-16.74K | ---88.46K | ---10.43K | ---34.43K | ---10.73K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -349.62%-22.11K | 118.01%36.03K | 25.13K | 107.52%15.05K | 772 | -4.92K | -200K | 0 | -200K | 0 |
Net investment purchase and sale | 75.35%35.22K | 130.51%61.03K | --25.13K | 107.52%15.05K | --772 | --20.08K | ---200K | --0 | ---200K | --0 |
Net other investing changes | -129.29%-57.32K | ---25K | --0 | --0 | --0 | ---25K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -349.62%-22.11K | 118.01%36.03K | --25.13K | 107.52%15.05K | --772 | ---4.92K | ---200K | --0 | ---200K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 2.25M | 317.86%818.8K | 818.8K | 0 | 0 | 0 | 195.95K | 0 | 0 | |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | --195.95K | --0 | --0 | ---- |
Net other financing activities | --2.25M | --818.8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --2.25M | 317.86%818.8K | --818.8K | --0 | --0 | --0 | --195.95K | --0 | --0 | ---- |
Net cash flow | ||||||||||
Beginning cash position | 1,764.31%838.55K | -67.29%44.98K | -69.67%16.81K | -96.10%11.29K | -77.70%23.33K | -67.29%44.98K | --137.49K | --55.41K | --289.83K | --104.62K |
Current changes in cash | 10,537.14%2.26M | 957.82%793.57K | 7,980.15%821.74K | 102.35%5.51K | -106.50%-12.03K | 34.13%-21.65K | ---92.51K | ---10.43K | ---234.43K | --185.22K |
End cash Position | 13,183.47%3.1M | 1,764.31%838.55K | 1,764.31%838.55K | -69.67%16.81K | -96.10%11.29K | -77.70%23.33K | --44.98K | --44.98K | --55.41K | --289.83K |
Free cash from | 267.91%28.1K | 30.75%-61.26K | -112.76%-22.19K | 72.31%-9.53K | -19.28%-12.8K | 49.09%-16.74K | ---88.46K | ---10.43K | ---34.43K | ---10.73K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data